The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies*
Abstract
OBJECTIVE: Catecholaminergic inotropes have a place in the management of low output syndrome and decompensated heart failure but their effect on mortality is debated. Levosimendan is a calcium sensitizer that enhances myocardial contractility without increasing myocardial oxygen use. A meta-analysis was conducted to determine the impact of levosimendan on mortality and hospital stay. DATA SOURCES: BioMedCentral, PubMed, Embase, and the Cochrane Central Register of clinical trials were searched for pertinent studies. International experts and the manufacturer were contacted. STUDY SELECTION: Articles were assessed by four trained investigators, with divergences resolved by consensus. Inclusion criteria were random allocation to treatment and comparison of levosimendan vs. control. There were no restrictions on dose or time of levosimendan administration or on language. Exclusion criteria were: duplicate publications, nonadult studies, oral administration of levosimendan, and no data on main outcomes. DATA EXTRACTION: Study end points, main outcomes, study design, population, clinical setting, levosimendan dosage, and treatment duration were extracted. DATA SYNTHESIS: Data from 5,480 patients in 45 randomized clinical trials were analyzed. The overall mortality rate was 17.4% (507 of 2,915) among levosimendan-treated patients and 23.3% (598 of 2,565) in the control group (risk ratio 0.80 [0.72; 0.89], p for effect <.001, number needed to treat = 17 with 45 studies included). Reduction in mortality was confirmed in studies with placebo (risk ratio 0.82 [0.69; 0.97], p = .02) or dobutamine (risk ratio 0.68 [0.52-0.88]; p = .003) as comparator and in studies performed in cardiac surgery (risk ratio 0.52 [0.35; 0.76] p = .001) or cardiology (risk ratio 0.75 [0.63; 0.91], p = .003) settings. Length of hospital stay was reduced in the levosimendan group (weighted mean difference = -1.31 [-1.95; -0.31], p for effect = .007, with 17 studies included). A trend toward a higher percentage of patients experiencing hypotension was noted in levosimendan vs. control (risk ratio 1.39 [0.97-1.94], p = .053). CONCLUSIONS: Levosimendan might reduce mortality in cardiac surgery and cardiology settings of adult patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
Cited by
Packer, M., Colucci, W., Fisher, L., Massie, B. M., Teerlink, J. R., Young, J., Padley, R. J., Thakkar, R., Delgado-Herrera, L., Salon, J., et al. (2013) · JACC: Heart Failure · doi:10.1016/j.jchf.2012.12.004 · Cited by 436
Low-Cardiac-Output Syndrome After Cardiac Surgery
Lomivorotov, V. V., Efremov, S. M., Kirov, M. Y., Fominskiy, E. V., & Karaskov, A. M. (2017) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2016.05.029 · Cited by 315
Levosimendan for Hemodynamic Support after Cardiac Surgery
Landoni, G., Lomivorotov, V. V., Alvaro, G., Lobreglio, R., Pisano, A., Guarracino, F., Calabrò, M. G., Grigoryev, E. V., Likhvantsev, V. V., Salgado-Filho, M. F., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616325 · Cited by 300
Self-citationTargeting the sarcomere to correct muscle function
Hwang, P. M., & Sykes, B. D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4554 · Cited by 114
Causes and treatment of oedema in patients with heart failure
Clark, A. L., & Cleland, J. G. F. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.191 · Cited by 112
Metadata
- Authors
- Landoni, G., Biondi-Zoccai, G., Greco, M., Greco, T., Bignami, E., Morelli, A., Guarracino, F., & Zangrillo, A.
- Venue
- Critical Care Medicine
- Published
- 2012-02
- Volume
- 40
- Issue
- 2
- Pages
- 634-646
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2140740040
- Cited by
- 232
- References
- 1
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies*. https://app.cochat.ai/papers/10.1097/ccm.0b013e318232962a
- The paper
- Landoni, G., Biondi-Zoccai, G., Greco, M., Greco, T., Bignami, E., Morelli, A., Guarracino, F., & Zangrillo, A. (2012). Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies*. Critical Care Medicine. https://doi.org/10.1097/ccm.0b013e318232962a
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.